Figures and Tables
From the following article:
The design of drugs for HIV and HCV
Erik De Clercq
Nature Reviews Drug Discovery 6, 1001-1018 (December 2007)
doi:10.1038/nrd2424
Figure 1
Simplified flow charts of the life cycles of human immunodeficiency virus (HIV) and hepatitis C virus (HCV).
Figure 2
Human immunodeficiency virus (HIV) reverse transcriptase.
Figure 3
Nucleoside and non-nucleoside reverse transcriptase inhibitors.
Figure 4
NS5B RNA replicase inhibitors: part 1.
Figure 5
NS5B RNA replicase inhibitors: part 2.
Figure 6
Human immunodeficiency virus (Hiv) protease inhibitors.
Figure 7
NS3 hepatitis C virus (HCV) protease inhibitors.
Figure 8
Inhibiting human immunodeficiency virus (HIV) fusion.
Figure 9
Human immunodeficency virus (HIV) co-receptor antagonists.
Figure 10
Human immunodeficiency virus (HIV) integrase inhibitors.
Figure 11
Human immunodeficiency virus (HIV) maturation inhibition.